% Expired Patents = 25.0

EPO Patents = 1

Forward Citations = 22

Loading Chart...

2 inventors (with patents filed for the assignee):

Ross Bersot (4 out of 6 patents)

Paul Humphries (4 out of 8 patents)

4 patents: Sort by Forward Citations

1. 10214507 - Carbazole-containing amides, carbamates, and ureas as cryptochrome modulators (2019-02-26),

2. 10005759 - Carbazole-containing amides, carbamates, and ureas as cryptochrome modulators (2018-06-26),

3. 9775845 - Carbazole-containing sulfonamides as cryptochrome modulators (2017-10-03),

4. 9265772 - Carbazole-containing sulfonamides as cryptochrome modulators (2016-02-23),

Company Overview

Reset Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for metabolic diseases. Their innovative approach targets biological pathways to reset circadian rhythms, improve metabolic function, and ultimately deliver transformative treatments for patients.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#848 in San Jose, CA

#14,058 in California

#60,671 in US

San Jose, CA, United States of America

Reset Therapeutics, Inc.

Forward Citations = 22

2 inventors:

Ross Bersot (4 out of 6 patents)

Paul Humphries (4 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Reset Therapeutics, Inc.. Retrieved from https://idiyas.com/company/reset-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]